The technology of tomorrow …

The fastest gateway to a successful launch is by choosing the right lead compound early. N2MO’s ex vivo models can provide guidance to you in your early drug discovery choices!

Contact us

N2MO A/S
Islandsbrygge 79C, 8502
DK-2300 København S
Denmark

Phone: +45 3134 4896

Funding

N2MO Granted Award as Best Investment Opportunity 2015

The Business Angels Networks in Denmark held their annual meeting 2015 in Odense on the 21st. of May. In a very intense competition, N2MO was granted the winning position based on the level of interest in investing in the company. The meeting creates a unique platform for innovative start-up companies to meet with investors as […]

By |June 4th, 2015|About N2MO, Funding|

Funding for The Project “Insect Models for Drug Discovery”

The Project “Insect Models for Drug Discovery” has received funding from the Danish National Advanced Technology Foundation.
The vision of the project is to establish insects, as a novel model organism in preclinical research.

EntomoPharm has previously developed two models for ADME drug screening in locusts. From this work and from preliminary insect studies it is evident […]

By |January 2nd, 2012|Funding|